(Q48159200)

9 February 2018

title

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. (English)

1 reference

9 February 2018

0 references

I Buchmann

1

1 reference

9 February 2018

M Henze

2

1 reference

9 February 2018

S Engelbrecht

3

1 reference

9 February 2018

M Eisenhut

4

1 reference

9 February 2018

A Runz

5

1 reference

9 February 2018

M Schäfer

6

1 reference

9 February 2018

T Schilling

7

1 reference

9 February 2018

S Haufe

8

1 reference

9 February 2018

T Herrmann

9

1 reference

9 February 2018

U Haberkorn

10

1 reference

9 February 2018

publication date

23 May 2007

1 reference

9 February 2018

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

9 February 2018

volume

34

1 reference

9 February 2018

issue

10

1 reference

9 February 2018

page(s)

1617-1626

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00259-007-0450-1

exact match

0 references

cites work

Abdominal lymphadenopathy: spectrum of CT findings

1 reference

12 December 2020

Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis

1 reference

12 December 2020

Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid

1 reference

12 December 2020

Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors

1 reference

12 December 2020

Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

1 reference

12 December 2020

Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland

1 reference

12 December 2020

Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis

1 reference

12 December 2020

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study

1 reference

12 December 2020

Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging

1 reference

12 December 2020

Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes

1 reference

12 December 2020

Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy

1 reference

12 December 2020

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.

1 reference

12 December 2020

Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance

1 reference

12 December 2020

Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET.

1 reference

12 December 2020

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

12 December 2020

10.1007/S00259-007-0450-1

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

17520251

1 reference

9 February 2018